Cancer Biology & Medicine

 


Cancer Biology & Medicine

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative andsignificant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:

● Cancer genetics

● Cancer and stem cell biology

● Molecular and clinical immunology

● Cancer prevention and epidemiology

● Cancer biomarkers

● Radiation oncology

● Oncology clinical trials

● Mechanisms of drug sensitivity and resistance

● Targeted therapy and immunotherapy

● Multidisciplinary treatment and personalized medicine

Author Benefits

● Easy submission via online system

● Efficient and professional peer review

● Rapid pre-print online publication

● No charge for publication and open access

● International visibility-All full texts are free in PubMed Central

 

Announcements

 

Publication of the 2nd issue in 2017

 

The latest issue of Cancer Biology & Medicine has been published on May 15th. It highlighted pathways referring to cancer metastasis and tumor microenvironment, oncologic immunology, novel strategy for detection of Lynch syndrome, biologic prognostic model of diffuse large B-cell lymphoma, vitamin D receptor expression in cutaneous melanoma, chemoradiotherapy-associated oral lesions in oral squamouscell carcinoma, and so on. We hope the articles in this issue will benefit your research and clinical practice. Click here to read fulltexts.

 
Posted: 2017-05-15
 

Great News: Science Citation Index Expanded indexed Cancer Biology & Medicine

 

We are so excited to declare that Cancer Biology & Medicine has been selected for coverage in Science Citation Index Expanded (SCIE) (see the figure below).


Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-Cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. From 2017, the new publication dates of the four issues are February 15th, May 15th, August 15th, and November 15th, respectively.


Except for SCIE, the journal has been indexed by PubMed/ PubMed Central, BIOSIS Previews, EMBASE, SCOPUS, EBSCO, DOAJ, and Chemical Abstracts. And it is a member of the Committee on Publication Ethics (COPE) and CrossRef.


We express sincere thankfulness to our authors, peer reviewers, and readers for their kind support in the past years. We warmly welcome you to submit your next work to Cancer Biology & Medicine.


Click here to visit the webpage of our journal in Clarivate Analytics (formerly the IP & Science business of Thomson Reuters): http://ip-science.thomsonreuters.com/cgi-bin/jrnlst/jlresults.cgi?PC=MASTER&Full=Cancer%20Biology%20%26%20Medicine

Here is the link to the journal page in PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/journals/2000/

 
Posted: 2017-04-21
 
More Announcements...

Vol 14, No 2: May 2017

Table of Contents

Review

Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog PDF
Armel Herve Nwabo Kamdje, Paul Takam Kamga, Richard Tagne Simo, Lorella Vecchio, Paul Faustin Seke Etet, Jean Marc Muller, Giulio Bassi, Erique Lukong, Raghuveera Kumar Goel, Jeremie Mbo Amvene, Mauro Krampera 109-120
Cellular immunity augmentation in mainstream oncologic therapy PDF
Daohong Chen, Xiaoshi Zhang 121-128
Mesenchymal stromal cells’ role in tumor microenvironment: involvement of signaling pathways PDF
Armel Herve Nwabo Kamdje, Paul Takam Kamga, Richard Tagne Simo, Lorella Vecchio, Paul Faustin Seke Etet, Jean Marc Muller, Giulio Bassi, Erique Lukong, Raghuveera Kumar Goel, Jeremie Mbo Amvene, Mauro Krampera 129-141

Original Article

Simplified microsatellite instability detection protocol provides equivalent sensitivity to robust detection strategies in Lynch syndrome patients PDF
Hadi Babaei, Mehrdad Zeinalian, Mohammad Hassan Emami, Mortaza Hashemzadeh, Najmeh Farahani, Rasoul Salehi 142-150
Significance of stromal-1 and stromal-2 signatures and biologic prognostic model in diffuse large B-cell lymphoma PDF
Asmaa Gaber Abdou, Nancy Asaad, Mona Kandil, Mohammed Shabaan, Asmaa Shams 151-161
Immunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms PDF
Francesco La Marra, Giuseppe Stinco, Cinzia Buligan, Giovanni Chiriacò, Diego Serraino, Carla Di Loreto, Sabina Cauci 162-175
Concomitant-chemoradiotherapy-associated oral lesions in patients with oral squamous-cell carcinoma PDF
Sadia Minhas, Muhammad Kashif, Wasif Altaf, Nadeem Afzal, Abdul Hanan Nagi 176-182

Case Report

Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report PDF
Peng Wang, Pei Xiao, Yingnan Ye, Pengpeng Liu, Lei Han, Li Dong, Chunhua She, Jinpu Yu 183-186
Aggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review PDF
Mehdi Afrit, Meher Nasri, Soumaya Labidi, Nesrine Mejri, Houda El Benna, Hamouda Boussen 187-190
Prognosis of gestational choriocarcinoma diagnosed incidentally during laparoscopy for a presumed cornual pregnancy: a report of five cases PDF
Shiping Liu, Chenchen Fan, Fengzhi Feng, Yang Xiang, Xirun Wan, Tong Ren 191-193
Littoral-cell angioma of the spleen: a case report PDF
Dongming Liu, Zhaohui Chen, Tongtong Wang, Baichang Zhang, Hongyuan Zhou, Qiang Li 194-195

Erratum

Erratum to Genetic and molecular changes in ovarian cancer PDF
Robert L Hollis, Charlie Gourley 196-201


OUR FRIENDS